Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ACACB | O00763 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | ACE | P12821 | 1/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7104098 | 0.88 | EPHX2 (0.37) | ALDH1A1ACACBPSMB5 | |
| SCHEMBL7109567 | 0.83 | CTSC (0.33) | ALDH1A1KMT2AACACBMMP1EPHX1 | |
| SCHEMBL7107121 | 0.77 | MMP13 (0.35) | KMT2AMMP1 | |
| SCHEMBL7109633 | 0.76 | EPHX2 (0.37) | ALDH1A1ACACBPSMB5 | |
| SCHEMBL7109634 | 0.75 | EPHX2 (0.36) | ALDH1A1KMT2AACACBMMP1PSMB5 | |
| SCHEMBL7105221 | 0.75 | ATM (0.39) | KMT2AMMP1 | |
| SCHEMBL6399627 | 0.71 | EPHX2 (0.37) | ALDH1A1ACACBPSMB5 | |
| SCHEMBL7772833 | 0.66 | USP21 (0.39) | ALDH1A1EPHX1ACE | |
| SCHEMBL7772818 | 0.65 | CACNA1B (0.39) | ALDH1A1ACACBPSMB5 | |
| SCHEMBL7105591 | 0.64 | MEN1 (0.43) | ALDH1A1KMT2AACACBPSMB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030013725-A1 | Amino acid derivatives | ONO PHARMACEUTICAL CO., LTD. | 2003-01-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030013725-A1 | Amino acid derivatives | CACNA1B, SCN1A, SCN2A | ALDH1A1 3065/4885KMT2A 1929/4885ACACB 1823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.